Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Aneuploidy Enables Cross-Adaptation to Unrelated Drugs

Open access

Abstract

Aneuploidy is common both in tumor cells responding to chemotherapeutic agents and in fungal cells adapting to antifungal drugs. Because aneuploidy simultaneously affects many genes, it has the potential to confer multiple phenotypes to the same cells. Here, we analyzed the mechanisms by which Candida albicans, the most prevalent human fungal pathogen, acquires the ability to survive both chemotherapeutic agents and antifungal drugs. Strikingly, adaptation to both types of drugs was accompanied by the acquisition of specific whole-chromosome aneuploidies, with some aneuploid karyotypes recovered independently and repeatedly from very different drug conditions. Specifically, strains selected for survival in hydroxyurea, an anticancer drug, acquired cross-adaptation to caspofungin, a first-line antifungal drug, and both acquired traits were attributable to trisomy of the same chromosome: loss of trisomy was accompanied by loss of adaptation to both drugs. Mechanistically, aneuploidy simultaneously altered the copy number of most genes on chromosome 2, yet survival in hydroxyurea or caspofungin required different genes and stress response pathways. Similarly, chromosome 5 monosomy conferred increased tolerance to both fluconazole and to caspofungin, antifungals with different mechanisms of action. Thus, the potential for cross-adaptation is not a feature of aneuploidy per se; rather, it is dependent on specific genes harbored on given aneuploid chromosomes. Furthermore, pre-exposure to hydroxyurea increased the frequency of appearance of caspofungin survivors, and hydroxyurea-adapted C. albicans cells were refractory to antifungal drug treatment in a mouse model of systemic candidiasis. This highlights the potential clinical consequences for the management of cancer chemotherapy patients at risk of fungal infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/molbev/msz104

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Candida albicans survivors of anticancer drugs show unstable colony phenotypes and variable ploidy levels. (A) Dose–response curves of C. albicans SC5314 exposed to a range of concentrations of the following anticancer drugs: hydroxyurea (HU), methotrexate (MTX), cisplatin (CDDP), and 5-fluorouracil (5-FU). Cultures were grown in YPD with HU, CDDP, or 5-FU, and in YNB with MTX. Data shown are the average of three technical repeats. Cell growth was monitored at intervals of 60 min in 100-ml flasks and 20 ml of culture medium at 37 °C for up to 6 h, with an initial cell density of 106 cells/mL. OD readings were obtained using cuvettes and a spectrophotometer. As previously reported, HU induced filamentous growth, which skews OD readings upward, but this had no qualitative consequence on the conclusion that HU dose-dependently inhibits C. albicans growth. (B) Small and large colonies appearing on rich medium with no drug (YPD), after restreaking cells that originally survived 2.814 mg/ml HU treatment. (C) Ability of small and large colonies, obtained from (B), to survive (i.e., to form colonies) in HU. Survival rate was calculated as the percentage of colonies growing on 2.814 mg/ml HU relative to the total number of colonies growing on YPD medium without drug. (D) Range of ploidy levels, determined by flow cytometry analysis of DNA content, in cells that survived exposure to the drug at the indicated concentrations. The ploidy distributions are shown as violin plots. The interquartile range is represented by a red box, whereas the median value is indicated by a white dot.
Fig. 1. Candida albicans survivors of anticancer drugs show unstable colony phenotypes and variable ploidy levels. (A) Dose–response curves of C. albicans SC5314 exposed to a range of concentrations of the following anticancer drugs: hydroxyurea (HU), methotrexate (MTX), cisplatin (CDDP), and 5-fluorouracil (5-FU). Cultures were grown in YPD with HU, CDDP, or 5-FU, and in YNB with MTX. Data shown are the average of three technical repeats. Cell growth was monitored at intervals of 60 min in 100-ml flasks and 20 ml of culture medium at 37 °C for up to 6 h, with an initial cell density of 106 cells/mL. OD readings were obtained using cuvettes and a spectrophotometer. As previously reported, HU induced filamentous growth, which skews OD readings upward, but this had no qualitative consequence on the conclusion that HU dose-dependently inhibits C. albicans growth. (B) Small and large colonies appearing on rich medium with no drug (YPD), after restreaking cells that originally survived 2.814 mg/ml HU treatment. (C) Ability of small and large colonies, obtained from (B), to survive (i.e., to form colonies) in HU. Survival rate was calculated as the percentage of colonies growing on 2.814 mg/ml HU relative to the total number of colonies growing on YPD medium without drug. (D) Range of ploidy levels, determined by flow cytometry analysis of DNA content, in cells that survived exposure to the drug at the indicated concentrations. The ploidy distributions are shown as violin plots. The interquartile range is represented by a red box, whereas the median value is indicated by a white dot.CC BY · PubMed Central
Fig. 2. Candida albicans survivors of antifungal drugs show unstable colony phenotypes and variable ploidy levels. (A) Dose–response curves of C. albicans SC5314 exposed to caspofungin (CSP), 5-flucytosine (5-FC), fluconazole (FLC), and amphotericin B (AMB). Cell growth was monitored at intervals of 15 min in 96-well microtiter plates at 37 °C for 24 h. Data shown are the average of three technical repeats. (B) A range of colony sizes, primarily small with a few larger colonies, were evident when individual strains that survived 100 ng/ml CSP were replated onto rich medium with no drug (YPD). Based on the size difference between small and large colonies, two types of strains, as indicated, were distinguished. (C) Ability of small and large colonies, from (B), to survive (i.e., to form colonies) in 100 ng/ml CSP. Survival rate was determined as the percentage of colonies growing on 100 ng/ml CSP after 2 days of growth at 37 °C out of the total number of colonies that appeared on YPD medium without drug. (n = 32 and n = 28 for Type 1 and Type 2 strains, respectively.) (D) Range of ploidy levels, determined by flow cytometry analysis of DNA content, in cells that survived exposure to 100 ng/ml CSP. The ploidy distributions are shown as violin plots. The interquartile range is represented by a red box, whereas the median value is indicated by a white dot. (n = 8, 32 and 28, for the parental strain, Type 1 strains and Type 2 strains, respectively.)
Fig. 2. Candida albicans survivors of antifungal drugs show unstable colony phenotypes and variable ploidy levels. (A) Dose–response curves of C. albicans SC5314 exposed to caspofungin (CSP), 5-flucytosine (5-FC), fluconazole (FLC), and amphotericin B (AMB). Cell growth was monitored at intervals of 15 min in 96-well microtiter plates at 37 °C for 24 h. Data shown are the average of three technical repeats. (B) A range of colony sizes, primarily small with a few larger colonies, were evident when individual strains that survived 100 ng/ml CSP were replated onto rich medium with no drug (YPD). Based on the size difference between small and large colonies, two types of strains, as indicated, were distinguished. (C) Ability of small and large colonies, from (B), to survive (i.e., to form colonies) in 100 ng/ml CSP. Survival rate was determined as the percentage of colonies growing on 100 ng/ml CSP after 2 days of growth at 37 °C out of the total number of colonies that appeared on YPD medium without drug. (n = 32 and n = 28 for Type 1 and Type 2 strains, respectively.) (D) Range of ploidy levels, determined by flow cytometry analysis of DNA content, in cells that survived exposure to 100 ng/ml CSP. The ploidy distributions are shown as violin plots. The interquartile range is represented by a red box, whereas the median value is indicated by a white dot. (n = 8, 32 and 28, for the parental strain, Type 1 strains and Type 2 strains, respectively.)CC BY · PubMed Central
Fig. 3. YMAP analysis of DNA content and allele ratios for HU and CSP survivor colonies reveals recurrent aneuploidies. Whole-genome DNA sequences for parents and the derived HU or CSP survivors were analyzed and displayed using YMAP (Abbey et al. 2014). Arrows on the left indicate the relationship between strains and the colonies derived from them. Relevant karyotype information is summarized to the right of each map. Read depth (normalized to that of the diploid parent) is shown on the y-axis on a log2 scale converted to absolute copy numbers (1–4). Allelic ratios (A:B) are color-coded: gray, 1:1 (A/B); cyan, 1:0 (A or A/A); magenta, 0:1 (B or B/B); purple, 1:2 (A/B/B); blue, 2:1 (A/A/B); light blue, 3:1 (A/A/A/B). The karyotype of strain CAI4 F2, which is euploid except for Chr2x3, was previously published and therefore not included in this analysis (Selmecki et al. 2005; Abbey et al. 2011).
Fig. 3. YMAP analysis of DNA content and allele ratios for HU and CSP survivor colonies reveals recurrent aneuploidies. Whole-genome DNA sequences for parents and the derived HU or CSP survivors were analyzed and displayed using YMAP (Abbey et al. 2014). Arrows on the left indicate the relationship between strains and the colonies derived from them. Relevant karyotype information is summarized to the right of each map. Read depth (normalized to that of the diploid parent) is shown on the y-axis on a log2 scale converted to absolute copy numbers (1–4). Allelic ratios (A:B) are color-coded: gray, 1:1 (A/B); cyan, 1:0 (A or A/A); magenta, 0:1 (B or B/B); purple, 1:2 (A/B/B); blue, 2:1 (A/A/B); light blue, 3:1 (A/A/A/B). The karyotype of strain CAI4 F2, which is euploid except for Chr2x3, was previously published and therefore not included in this analysis (Selmecki et al. 2005; Abbey et al. 2011).CC BY · PubMed Central
Fig. 4. Extra copies of chromosome 2 increase growth ability in the presence of hydroxyurea and caspofungin. The growth ability of representative strains was tested in YPD medium supplemented with HU (A) or CSP (B) at concentrations indicated. Growth was measured by absorbance at 600 nm after 36 h at 37 °C. Optical densities were standardized to those of drug-free controls and averaged across three technical replicates. Data were quantitatively displayed as color intensities as indicated in the color bar key on the right, using a custom python script.
Fig. 4. Extra copies of chromosome 2 increase growth ability in the presence of hydroxyurea and caspofungin. The growth ability of representative strains was tested in YPD medium supplemented with HU (A) or CSP (B) at concentrations indicated. Growth was measured by absorbance at 600 nm after 36 h at 37 °C. Optical densities were standardized to those of drug-free controls and averaged across three technical replicates. Data were quantitatively displayed as color intensities as indicated in the color bar key on the right, using a custom python script.CC BY · PubMed Central
Fig. 5. Role of RNR gene copy numbers for ability to grow in HU, but not in CSP. Strains with different numbers of alleles of RNR1, RNR21, and RNR22 were constructed by one of two strategies: (A) by deletion of one gene copy from diploid strain SC5314, followed by chromosome duplication via exposure to HU or CSP or (B) by deletion of one gene copy from a Chr2 trisomic strain. Strains were spotted (3 µl/spot, 10-fold dilutions) onto HU or CSP plates and incubated at 37 °C for 48 h. All strains in (A) and in (B) were analyzed on the same drug plates. Comparison of mutant growth should be made between euploid strains or between trisomic strains. For example, the Chr2x3 strain (FY376) is a control for all strains in (A) and (B).
Fig. 5. Role of RNR gene copy numbers for ability to grow in HU, but not in CSP. Strains with different numbers of alleles of RNR1, RNR21, and RNR22 were constructed by one of two strategies: (A) by deletion of one gene copy from diploid strain SC5314, followed by chromosome duplication via exposure to HU or CSP or (B) by deletion of one gene copy from a Chr2 trisomic strain. Strains were spotted (3 µl/spot, 10-fold dilutions) onto HU or CSP plates and incubated at 37 °C for 48 h. All strains in (A) and in (B) were analyzed on the same drug plates. Comparison of mutant growth should be made between euploid strains or between trisomic strains. For example, the Chr2x3 strain (FY376) is a control for all strains in (A) and (B).CC BY · PubMed Central
Fig. 6. Calcium and the calcineurin pathway are required for improved survival on caspofungin, but not on hydroxyurea. (A) Parental strain SC5314 was plated (∼106 cells per plate) onto YPD supplemented with HU (2.814mg/ml) or CSP (100 ng/ml) alone, or in combination with calcium chloride (100 mM) or inhibitors of the calcineurin pathway, FK506 (0.5 µg/ml) and cyclosporin A (CsA) (0.5 µg/ml), as indicated. (B) Parental strains YJBT545 and YJBT736, and isogenic derivatives lacking genes CNA1, CNB1 (encoding calcineurin subunits) or CRZ1 (encoding a transcription factor downstream of the calcineurin pathway) were plated on YPD plates supplemented with HU (2.814mg/ml) or CSP (100 ng/ml) at 37 °C for 3 days. Note that growth on CSP, but not HU, is enhanced with added calcium and inhibited both by inhibitors of, and mutants affecting, the calcineurin pathway.
Fig. 6. Calcium and the calcineurin pathway are required for improved survival on caspofungin, but not on hydroxyurea. (A) Parental strain SC5314 was plated (∼106 cells per plate) onto YPD supplemented with HU (2.814mg/ml) or CSP (100 ng/ml) alone, or in combination with calcium chloride (100 mM) or inhibitors of the calcineurin pathway, FK506 (0.5 µg/ml) and cyclosporin A (CsA) (0.5 µg/ml), as indicated. (B) Parental strains YJBT545 and YJBT736, and isogenic derivatives lacking genes CNA1, CNB1 (encoding calcineurin subunits) or CRZ1 (encoding a transcription factor downstream of the calcineurin pathway) were plated on YPD plates supplemented with HU (2.814mg/ml) or CSP (100 ng/ml) at 37 °C for 3 days. Note that growth on CSP, but not HU, is enhanced with added calcium and inhibited both by inhibitors of, and mutants affecting, the calcineurin pathway.CC BY · PubMed Central
Fig. 7. Effect of HU pre-exposure on cross-adaptation to caspofungin. Parental strain SC5314 was passaged daily for 7 days in YPD+HU (IC50; 2.814 mg/ml) at 37 °C, washed, and growth was measured on either solid (A) or liquid (B) medium. (A) ∼1 × 105 cells were plated on YPD plates (with or without CSP [100 ng/ml] as indicated) and incubated at 37 °C for 3 days. (B) Passaged cells (with or without HU from the pre-exposure period above) were plated on YPD at a cell density of ∼200 CFUs/plate and incubated at 37 °C for 24 h. From each plate, 94 colonies from the control YPD treatment (gray curves), and 94 colonies from the YPD+HU treatment (blue curves) were randomly selected and grown at 37 °C in YPD with or without CSP (100 ng/ml); parental strain without pre-exposure was also tested (red curves). Growth was measured as absorbance at 600 nm every 15 min. (C) Strains evolved for 7 days as above were analyzed by spot assays. Serial dilutions of cell suspension were spotted (3 µl/spot) on YPD plates supplemented with the indicated concentrations of HU or CSP and incubated at 37 °C for 48 h. Each condition was tested a minimum of three independent times. Growth is represented in a heat map comparing strains with or without Chr2 trisomy (Chr2x3, euploid, respectively), as described in methods.
Fig. 7. Effect of HU pre-exposure on cross-adaptation to caspofungin. Parental strain SC5314 was passaged daily for 7 days in YPD+HU (IC50; 2.814 mg/ml) at 37 °C, washed, and growth was measured on either solid (A) or liquid (B) medium. (A) ∼1 × 105 cells were plated on YPD plates (with or without CSP [100 ng/ml] as indicated) and incubated at 37 °C for 3 days. (B) Passaged cells (with or without HU from the pre-exposure period above) were plated on YPD at a cell density of ∼200 CFUs/plate and incubated at 37 °C for 24 h. From each plate, 94 colonies from the control YPD treatment (gray curves), and 94 colonies from the YPD+HU treatment (blue curves) were randomly selected and grown at 37 °C in YPD with or without CSP (100 ng/ml); parental strain without pre-exposure was also tested (red curves). Growth was measured as absorbance at 600 nm every 15 min. (C) Strains evolved for 7 days as above were analyzed by spot assays. Serial dilutions of cell suspension were spotted (3 µl/spot) on YPD plates supplemented with the indicated concentrations of HU or CSP and incubated at 37 °C for 48 h. Each condition was tested a minimum of three independent times. Growth is represented in a heat map comparing strains with or without Chr2 trisomy (Chr2x3, euploid, respectively), as described in methods.CC BY · PubMed Central
Fig. 8. Survival curves of C57BL/6J mice systemically infected with wild-type or HU-evolved Candida albicans strains harboring either ChrRx3 or Chr2x3, with or without CSP treatment. CSP was administered intraperitoneally at a dose of 0.063 mg/kg body weight daily for 7 days, beginning 1 day after infection. Control mice were administered 100 μl of phosphate buffered saline intraperitoneally. Survival curves were compared using the log-rank test.
Fig. 8. Survival curves of C57BL/6J mice systemically infected with wild-type or HU-evolved Candida albicans strains harboring either ChrRx3 or Chr2x3, with or without CSP treatment. CSP was administered intraperitoneally at a dose of 0.063 mg/kg body weight daily for 7 days, beginning 1 day after infection. Control mice were administered 100 μl of phosphate buffered saline intraperitoneally. Survival curves were compared using the log-rank test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Cited by

See all 104

Metadata

Authors
Yang, F., Teoh, F., Tan, A. S. M., Cao, Y., Pavelka, N., & Berman, J.
Affiliations
  • Tel Aviv University (IL)
  • Agency for Science, Technology and Research (SG)
  • Shanghai University of Traditional Chinese Medicine (CN)
Corresponding author
  • Pavelka, Norman
  • Berman, Judith
Venue
Molecular Biology and Evolution
Published
2019-04-27
Volume
36
Issue
8
Pages
1768-1782
ISSN
  • 0737-4038 (ISSN-L)
  • 1537-1719
OpenAlex
W2940793950
Cited by
101
References
91
Citations by year
2026: 9 · 2025: 13 · 2024: 13 · 2023: 15 · 2022: 15 · 2021: 17 · 2020: 13 · 2019: 6
FWCI
4.22
Type
journal article
Language
en
Open access
Locations
  • Molecular Biology and Evolution (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • European Research Council (340087)
  • Agency for Science, Technology and Research (JCO/1437a00117)
  • Singapore Immunology Network
  • National Science Foundation of China (81872910)
  • A*STAR Graduate Scholarship
  • PBC China-Israel Postdoctoral Fellowship Program
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords
aneuploidy, cross-adaptation, Candida albicans, drug tolerance, antifungal resistance, chemoresistance, hydroxyurea, caspofungin, fluconazole, trisomy, monosomy, chromosome 2, chromosome 5, stress response pathways, systemic candidiasis, fungal pathogens
MeSH terms
Caspofungin, Adaptation, Biological, Aneuploidy, Animals, Antifungal Agents, Antineoplastic Agents, Candida albicans, Hydroxyurea, Chromosomes, Fungal, Calcineurin, Drug Resistance, Fungal, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aneuploidy Enables Cross-Adaptation to Unrelated Drugs. https://app.cochat.ai/papers/10.1093/molbev/msz104
The paper
Yang, F., Teoh, F., Tan, A. S. M., Cao, Y., Pavelka, N., & Berman, J. (2019). Aneuploidy Enables Cross-Adaptation to Unrelated Drugs. Molecular Biology and Evolution. https://doi.org/10.1093/molbev/msz104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.